General description
INN
Ofloxacin
Medicine type
Chemical agent
Antibiotic groups
EML status history
First added in 1999
(TRS
895)
for
Multi-drug resistant Mycobacterium tuberculosis
Added in 2013
(TRS
985)
for
Infectious keratitis
Removed in 2013
(TRS
985)
for
Multi-drug resistant Mycobacterium tuberculosis
Added in 2021
(TRS
1035)
for
Other specified conjunctivitis
Changed in 2021
(TRS
1035)
for
Infectious diseases of external ear
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Ophthalmological preparations > Anti-infective agents
- Local > Ophthalmological > Solution (eye drops): 0.3%
Indications
Section
Antituberculosis medicines
- Oral > Solid: 200 mg; 400 mg
Indications